Mihoko Sutoh Yoneyama

Author

Also Known As

Hayato Yamamoto, M. Sutoh Yoneyama, M.S. Yoneyama, MIHOKO SUTOH YONEYAMA, Mihoko S. Yoneyama, Mihoko Sutoh Yoneyama, Mihoko Yoneyama, Mihoko Yoneyama*

Publications

378

Citations

H-Index

Concepts

All Affiliations

Hirosaki University Sanford Burnham Prebys Medical Discovery Institute Discovery Institute

About

Mihoko Sutoh Yoneyama is an author at Hirosaki University specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	240
2	Cell Biology	3	3	200
3	Cellular Physiology	2	2	140
4	Biostatistics	1	1	28
5	Immunology	1	1	60

Mihoko Sutoh Yoneyama

Publications

318

Citations

H-Index

Page 1

	Year	Citations
Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, European Journal of Cell Biology Cell AdhesionBiological MicroenvironmentsPathologyCancer Cell BiologyCell-matrix Interaction	2014	116
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity Teppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Molecular Medicine Reports GlycoproteomicsCancer ImmunosurveillanceGlycosylationMedicineCore2 O-glycans	2012	60
Clinical significance of the Lacdi<scp>NA</scp>c‐glycosylated prostate‐specific antigen assay for prostate cancer detection Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Cancer Science Prognostic BiomarkersUrologyUnnecessary Prostate BiopsiesSignificant Prostate CancerGenitourinary Cancer	2019	28
Extravasation during bladder cancer metastasis requires cortactin-mediated invadopodia formation Noriko Tokui, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Molecular Medicine Reports Lung MetastasisBladder Cancer MetastasisUrologyGenitourinary CancerMedicine	2014	24
The Impact of Glycosylation of Osteopontin on Urinary Stone Formation Go Anan, Tohru Yoneyama, Daisuke Noro, International Journal of Molecular Sciences	2019	20
Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, BMC Cancer	2021	18
A mechanism for evasion of CTL immunity by altered <i>O</i> -glycosylation of HLA class I Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, The Journal of Biochemistry	2016	17
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries Sakae Konishi, Takuma Narita, Shingo Hatakeyama, Scientific Reports	2021	13
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Urologic Oncology Seminars and Original Investigations Radical CystectomyUrologySurgical OncologyOncologyGenitourinary Cancer	2020	12
Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells Kengo Imanishi, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Molecular Medicine Reports	2014	10

Page 1